GPR119: a promising target for nonalcoholic fatty liver disease.
Yang JW, Kim HS, Im JH, Kim JW, Jun DW, Lim SC, Lee K, Choi JM, Kim SK, Kang KW.
Yang JW, et al. Among authors: kim sk, kim hs, kim jw.
FASEB J. 2016 Jan;30(1):324-35. doi: 10.1096/fj.15-273771. Epub 2015 Sep 23.
FASEB J. 2016.
PMID: 26399788